Significant Growth Expected in Exosome Diagnostic and Therapeutics Market by 2032 The Exosome Diagnostic and Therapeutics Market is projected to reach USD 401.70 million by 2032, fueled by advancements in liquid biopsy and precision medicine.

Significant Growth Expected in Exosome Diagnostic and Therapeutics Market by 2032 #None #Liquid_Biopsy #Precision_Medicine #Exosome_Diagnostics

Bio-Techne Corporation Reports Fourth Quarter Results for Fiscal Year 2025 Bio-Techne Corporation announces its financial performance for the fourth quarter of FY2025, highlighting revenue growth and strategic business divestitures.

Bio-Techne Corporation Reports Fourth Quarter Results for Fiscal Year 2025 #United_States #Minneapolis #Bio-Techne #Fiscal_2025 #Exosome_Diagnostics

Bio-Techne Sells Exosome Diagnostics to Mdxhealth to Strengthen Precision Diagnostics Bio-Techne has finalized a deal to sell its Exosome Diagnostics business to Mdxhealth, enhancing their focus on innovative precision diagnostics.

Bio-Techne Sells Exosome Diagnostics to Mdxhealth to Strengthen Precision Diagnostics #USA #Minneapolis #Bio-Techne #Exosome_Diagnostics #Mdxhealth

Exosome Diagnostics and Therapeutics Market Growth Driven by AI Innovations and Research Advancements The exosome diagnostics and therapeutics market is set to grow by USD 1.01 billion from 2025 to 2029, driven by AI and advanced research in therapeutics.

Exosome Diagnostics and Therapeutics Market Growth Driven by AI Innovations and Research Advancements #None #AI_Innovations #Exosome_Diagnostics #Therapeutics_Market